Novoprotein Scientific Inc. (SHA:688137)
China · Delayed Price · Currency is CNY 122.84
-1.66 (-1.33%)
At close: Sep 23, 2026
Novoprotein Scientific Market Cap
Novoprotein Scientific has a market cap or net worth of 8.54 billion as of September 23, 2026. Its market cap has increased by 198.07% in one year.
Market Cap
8.54B
Enterprise Value
6.94B
Revenue
152.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
122.84
ChartMarket Cap Chart
Since September 29, 2022, Novoprotein Scientific's market cap has increased from 5.30B to 8.54B, an increase of 61.15%. That is a compound annual growth rate of 12.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 8.54B | 205.58% |
| Dec 31, 2025 | 2.79B | 20.54% |
| Dec 31, 2024 | 2.32B | -40.46% |
| Dec 29, 2023 | 3.89B | -27.00% |
| Dec 30, 2022 | 5.33B | 0.65% |
| Sep 29, 2022 | 5.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daan Gene | 7.89B |
| Beijing Hotgen Biotech | 7.78B |
| Innovita Biological Technology | 7.65B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 7.47B |
| Novogene | 7.36B |
| Chengdu Kanghua Biological Products | 7.06B |
| Jiangsu Aidea Pharmaceutical Group | 6.98B |
| PharmaResources (Shanghai) | 6.96B |